Research Antibodies & Reagents Market worth $16.2 billion by 2028 - Exclusive Report by MarketsandMarkets™

 The rise in outsourcing is a positive development for the research antibodies and reagents market. By outsourcing the development and production of antibodies and reagents, companies can reduce costs, increase efficiency, access expertise, and increase flexibility, thus creating opportunities in the research antibodies and reagents market. Also, an increasing number of local players in emerging markets, such as China, India, and Mexico, are offering their research antibodies and reagents products at lower prices than established market players. As a result, the pricing pressure on established players has increased, who are being compelled to adopt competitive pricing strategies to maintain their market shares and this is challenging market growth.

The report Research Antibodies & Reagents Market  are projected to reach USD 16.2 billion by 2028 from USD 11.8 billion in 2023, at a CAGR of 6.5% during the forecast period.

Download PDF Brochure: -

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793

Key Market Dynamics:

Growth Drivers

• Increasing research activity and funding for R&D
• Growing industry-academia collaboration

Growth Opportunities

• Emerging markets
• Personalized medicine and protein therapeutics
• Growth in stem cell and neurobiology research
• Increasing focus on biomarker discovery
• Rising interest in outsourcing

Challenges

• Cost and time-intensive antibody development processes
• Pricing pressure faced by prominent market players.

Trends

• Increasing research on therapeutic antibodies
• Recombinant antibodies supporting the smooth transition from in vitro to in vivo
• Growing consolidation of the life sciences market for antibodies and reagents

Market Segmentation: -

On the basis of the product, the research antibodies and reagents market are segmented into reagents and antibodies. The antibodies segment is expected to grow at highest CAGR in forecast periods (2023-2028). Antibodies are essential for routine procedures, such as western blotting, flow cytometry, IHC, and ELISA.

On the basis of form, the research-use antibodies are categorized into monoclonal, polyclonal, and recombinant antibodies. The monoclonal antibodies segment accounted for the largest share of the research antibodies market by form in 2022.

On the Basis of type, the research reagents market are segmented into media &sera, stains & dyes, fixatives, buffers, solvents, enzymes, probes, and other reagents. In 2022, the media & sera reagent segment held the largest share of the global research reagents market.

On the basis of technology, the research antibodies and reagents market are segmented into ELISA, flow cytometry, western blotting, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and other technologies. In 2022, the Enzyme-linked Immunosorbent Assay (ELISA) segment accounted for the largest share of the market.

On the basis of application, the research antibodies and reagents market are segmented into proteomics, drug development and Genomics. In 2022, the proteomics segment accounted for the largest share.

On the basis of end user, the research antibodies and reagents market are segmented into the pharmaceutical & biotechnology companies, research labortories, and Contract Research Organizations. The research laboratories segment accounted for the largest share of the market in 2022.

Regional Analysis:

The European market is expected to have the second largest market share in 2022. The growth of the overall market in Europe is attributed to an increase in R&D activities, rising government funding for drug discovery research, and increasing growth in the pharmaceutical & biological industries. In Europe, proteomics and genomics research for cancer and neurobiological diseases have increased in the last decade. between universities that are designed to promote excellence in research and education.

Recent Developments of Research Antibodies & Reagents Industry

• In August 2023, Danaher (US) entered into a definitive agreement to acquire all the outstanding shares of Abcam plc (UK). Through this development, Abcam is expected to operate as a standalone operating company within Danaher’s Life Sciences segment.
• In August 2023, Agilent Technologies, Inc. (US) announced the opening of a new full-scale Integrated Biology Center located at Monash University in Malaysia. The facility is focused on building local capabilities to accelerate research and development (R&D) in life science research.
• In June 2023, Cell Signaling Technology, Inc. (US) and Lunaphore Technologies SA (Switzerland) have decided to partner to integrate CST antibodies into Lunaphore's COMET platform for Spatial Biology research.

Request For Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=94212793

Top Key Players: -

The prominent market players are Abcam plc (UK), Cell Signaling Technology, Inc. (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), BD (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (US), Danaher (US), Lonza (Switzerland), GenScript (China), and Revvity (US).

 

 

Research Antibodies & Reagents Market Size, Share | 2022 - 2027 |

 "Research Antibodies and Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End User (Pharma, Biotech, CROs) - Global forecast to 2027", published by MarketsandMarkets™, the global Research Antibodies and Reagents Market are projected to reach USD 16.1 billion by 2027 from USD 11.6 billion in 2022, at a CAGR of 6.7% during the forecast period.

Browse in-depth TOC on "Research Antibodies Market and Research Reagents Market"
244 – Tables
46 – Figures
285 – Pages

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793

The Factors responsible for driving the market are, increasing growth in proteomics and genomics research, growing demand for high-quality antibodies for research reproducibility, and increasing R&D investments in the life sciences industry.

The antibodies segment is expected to grow at the highest CAGR during the forecast period

On the basis of product, the research antibodies and reagents market are segmented into reagents and antibodies. The antibodies segment is expected to grow at highest CAGR in forecast periods (2022-2027). Factors such as antibodies use for research offer high specificity and selectivity and are used ubiquitously in biochemical and medical research for protein-target identification, regulatory characterization, and discovery, are driving the market.

The primary antibodies segment is accounts for the largest share of the research antibodies and reagents market

On the basis of type, the research reagents market are segmented into primary antibodies and secondary antibodies. In 2021, the primary antibodies segment held the largest share of the global research antibodies market. This segment is witnessing a strong growth due to the use of these antibodies in numerous types of assay formats. Their accuracy in biomarker detection and high specificity and sensitivity are also driving the market.

The media & sera reagent is expected to account for the largest share of the market, by type, in 2021

On the Basis of type, the research antibodies and reagents market are segmented into media &sera, stains & dyes, fixatives, buffers, solvents, enzymes, probes, and other reagents. In 2021, the media & sera reagent segment held the largest share of the global research antibodies market. Factors such as use of these components in all types of assays, cell cultures, and techniques is driving the market.

Request Sample Pages: 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=94212793

The western blotting segment is expected to account for the largest share of the market, by technology, in 2021

On the basis of technology, the research antibodies and reagents market are segmented into western blotting, flow cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and other technologies. The Western blotting segment is expected to grow at highest CAGR in forecast periods (2022-2027). Factors such as the high adoption of technique in proteomic and genomic research. The results achieved are unique, easy to interpret, and unambiguous, making it suited for evaluating levels of protein expression in cells, protein purification, and comparing the expression of a target protein from various tissues.

The drug development applications segment is expected to grow at the highest CAGR during the forecast period

On the basis of application, the research antibodies and reagents market are segmented into proteomics, drug development and Genomics. The drug development segment is expected to grow at highest CAGR in forecast periods (2022-2027). Factors such increasing demand for personalized medicine and government funding & initiatives in the sector are the key market drivers for this segment.

The pharmaceutical & biotechnology segment is expected to grow at the highest CAGR during the forecast period

On the basis of end user, the research antibodies and reagents market are segmented into the pharmaceutical & biotechnology companies, academic & research institutions, and ontract Research Organizations. Factors such as the growth of this segment is due to antibodies provide a gold standard for the detection of a biomolecule or a pathway and are even capable of detecting specific changes in potential drug targets. Moreover, highly specific reagents are used to measure pharmacokinetic parameters in the preclinical and clinical development of biological drugs are the key market drivers for this segment.

Speak to Analyst: 
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=94212793

The APAC market is expected to grow at the highest CAGR during the forecast period

The Asia Pacific research reagents market is expected to grow at the highest CAGR from 2022 to 2027. Factors such as increasing proteomics and genomics research and growing research funding, increasing investments by pharmaceutical and biotechnology companies are driving the market.

The prominent market players are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Abcam plc (UK), Becton, Dickinson, and Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), and BioLegend (US).

Browse Related Reports:

Flow Cytometry Market by Technology (Cell-based, Bead-based), Product (Analyzer, Sorter, Reagents, Consumables, Software), End user (Academia, Research Labs, Hospitals, Clinical Laboratories, Pharma-Biotech Cos), Application - Global Forecasts to 2025
https://www.marketsandmarkets.com/Market-Reports/flow-cytometry-market-65374584.html

Thermo Fisher Scientific and Merck are the Leading Players in the Research Antibodies & Reagents Market

 The research antibodies and reagents market has evolved owing to factors such as growth in proteomics and genomics research, rising demand for high-quality antibodies for research reproducibility, and increasing R&D activity and expenditure in the life sciences industry. Fueled by the growing demand for personalized medicine and structure-based drug design, the global research antibodies and reagents market is expected to witness significant growth in the coming years.

The Research antibodies and reagents market is projected to reach USD 14.1 billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period.

Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793

The research antibodies and reagents market players are focusing on various organic and inorganic growth strategies, such as product launches, acquisition, collaboration, partnerships, agreements, and expansion to increase their market foothold. The prominent market players are Thermo Fisher Scientific (US), Merck Group (Germany), Abcam plc (UK), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), and BioLegend (US). The market is highly competitive, with a large number of leading market players based across developed regions such as the US and Europe. However, smaller players have emerged from niche markets to compete with global players on the basis of price and product innovation. Due to intense competition, major market players are increasingly focusing on expanding their geographic presence into the high-growth emerging markets and strengthening their market competitiveness by acquiring smaller players with the desired product quality or geographic presence.

 

Thermo Fisher Scientific Inc. develops and manufactures high-end analytical instruments, laboratory equipment, software, consumables, reagents, and services for scientific research, analysis, discovery, and diagnostics. The company serves customers through premier brands—Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services. The company operates through four basic segments, namely, Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products & Services. It provides reagents, instruments, and consumables used in biological and medical research, discovery, the production of new drugs and vaccines, and the diagnosis of diseases through its Life Sciences Solutions segment. The Life Sciences Solutions segment includes four primary businesses, of which the biosciences business provides various reagents and antibodies for conducting biological and medical research.The company operates in more than 180 countries across North America, Europe, Asia, the Middle East, Africa, and Latin America. Some of its major subsidiaries are ABgene Limited (UK), Athena Diagnostics, Inc. (US), Thermo Fisher Scientific C.V. (Netherlands), Life Technologies Corporation (US), Prionics AG (Switzerland), Thermo Detection de Mexico, S.A. de C.V., Fisher Scientific Japan, Ltd., and Fisher Scientific (SEA) Pte. Ltd. (Singapore).

Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION:-https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=94212793

The Merck Group is a multinational pharmaceutical, life science, and chemical company. The company has three major business divisions—Healthcare, Life Sciences, and Performance Materials. The Life Sciences division is organized into three business areas: research solutions, process solutions, and applied solutions. The products and services offered by the Life Sciences division are used in R&D and manufacturing of biotechnological and pharmaceutical drug therapies, as well as in research and application laboratories. The research solutions segment provides consumables for filtration and sample preparation, reagents and kits for cell biology experiments, and small tools and consumables for cell analysis. This segment mainly focusses on academia and pharmaceutical research institutions. The company provides more than 300,000 products across 66 countries. Its manufacturing facilities are l ocated in Bedford (US), Jaffrey (US), Darmstadt (Germany), Molsheim (France), Beijing (China), and Bengaluru (India). Merck has a strong product and technology portfolio for research antibodies and offers innovative solutions for the life science industry. The company offers high-quality research-use products to a wide end-user base under the brand name MilliporeSigma. With a strong brand and wide geographic coverage in more than 120 countries, Merck has a well-established presence in the research antibodies market. It also plans to expand its life science offerings by investing in R&D activities and through planned business synergies. In 2019, it invested around USD 2.54 billion in R&D activities.

 

Research Antibodies & Reagents Market: Trends and Opportunities

 The growth is due to evolution of market owing to factors such as growth in proteomics and genomics research, rising demand for high-quality antibodies for research reproducibility, and increasing R&D activity and expenditure in the life sciences industry. Fueled by the growing demand for personalized medicine and structure-based drug design, the global research antibodies and reagents market is expected to witness significant growth in the coming years.

The report Research Antibodies & Reagents Market  is projected to reach USD 14.1 billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period.

Ask for PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793

COVID-19 Impact: -

The COVID-19 outbreak has boosted research activity due to efforts to understand the dynamics of the infection. We estimate that the major share of research antibody and reagent manufacturing, along with personalized medicine, will grow at a stable pace in the next five years. Due to the increase in research activity, both the availability of funding for research and the demand & manufacturing of reagents and antibodies are expected to grow. As companies after pandemic have scaled up their operations for testing and tracking the infection of COVID-19. This has given a chance for growth in profits for companies operating in the NGS and PCR markets. The growth in revenue is 5–7%, as COVID-19 testing has increased with the use of the latest technology of genetic and molecular testing. The shift in demand for research for COVID-19, neurobiology, and oncology has created a huge scope for testing solutions, such as western blotting, flow cytometry, ELISA, and drugs for researchers and laboratories.

Market Segmentation: -

Based on product, the research antibodies market is segmented into reagents and antibodies. The antibodies segment is expected to grow at highest CAGR in forecast period. This is due to the research-use antibodies offer high specificity and selectivity and are used ubiquitously in biochemical and medical research for protein-target identification, regulatory characterization, and discovery.

Based type, the research reagents market is segmented into primary antibodies and secondary antibodies. The primary antibodies segment held the largest share of the global research antibodies market in 2019.

Based type, the research antibodies market is segmented into media &sera, stains & dyes, fixatives, buffers, solvents, enzymes, probes and other reagents. The media & sera reagent segment held the largest share of the global research antibodies market in 2019.

Based on technology, the research antibodies and reagents market is segmented into western blotting, flow cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and other technologies. Western blotting segment is expected to grow at highest CAGR in forecast periods (2020-2025).

Based on end user, the research reagents market is segmented into the pharmaceutical & biotechnology companies, academic & research institutions and Contract Research Organizations.

Request for sample Pages :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=94212793

Regional Analysis:-

The Asia Pacific research antibodies and reagents market is expected to grow at the highest CAGR from 2020 to 2025. Also, high-growth countries, such as China, India, Japan, South Korea, Taiwan, Australia, and Singapore are the major contributors to the Asia Pacific research antibodies and reagents market.